Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yukiko Shimoda
Observed names:
Y. Shimoda,
Y., Shimoda,
YUKIKO SHIMODA,
Yukiko Shimoda. Igawa
Institution:
National Cancer Centre Japan
Observed institutions:
Jikei University School of Medicine,
National Cancer Centre Japan,
National Center for Global Health and Medicine,
Shizuoka General Hospital,
National Cancer Center Hospital,
National Cancer Center Hospital
show all 6
ORCID:
0000-0003-1767-5840
Observed ORCID:
0000-0003-1767-5840
OpenAlex ID:
A5082596754
Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC
2021
·
Masayuki Shirasawa
, Tatsuya Yoshida
, et al.
·
Journal of Thoracic Oncology
·
75
PDF
Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients
2022
·
Yukiko Shimoda
, Ryota Shibaki
, et al.
·
Clinical Lung Cancer
·
20
PDF
Nivolumab versus pembrolizumab in previously-treated advanced non-small cell lung cancer patients: A propensity-matched real-world analysis
2022
·
Masahiro Torasawa
, Tatsuya Yoshida
, et al.
·
Lung Cancer
·
18
Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations
2023
·
Yukiko Shimoda
, Tatsuya Yoshida
, et al.
·
Cancer Immunology Immunotherapy
·
13
PDF
Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary tuberculosis
2019
·
Takahito Suzuki
, Toshihiro Shirai
, et al.
·
Respiratory Investigation
·
12
Smoking History Predicts High Presence of TILs and Efficacy of PD-1 Blockade in PD-L1 Expression-negative Non-small Cell Lung Cancer Patients
2021
·
YUKIKO SHIMODA
, TATSUYA YOSHIDA
, et al.
·
Anticancer Research
·
11
Forced oscillation technique as a predictor of FEV1 improvement in asthma
2016
·
Taisuke Akamatsu
, Toshihiro Shirai
, et al.
·
Respiratory Physiology & Neurobiology
·
11
Oscillometry as a Predictor of Exercise Tolerance in COPD
2020
·
Akito Yamamoto
, Toshihiro Shirai
, et al.
·
COPD Journal of Chronic Obstructive Pulmonary Disease
·
9
Case report: new development of fibrosing interstitial lung disease triggered by HIV-related pneumocystis pneumonia
2019
·
Tetsuya Suzuki
, Yukiko Shimoda
, et al.
·
BMC Pulmonary Medicine
·
9
PDF
Disease progression status during initial immune checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non‐small cell lung cancer patients
2023
·
Masahiro Torasawa
, Tatsuya Yoshida
, et al.
·
Cancer Medicine
·
8
PDF
Association of the forced oscillation technique with negative expiratory pressure in COPD
2015
·
Takefumi Akita
, Toshihiro Shirai
, et al.
·
Respiratory Physiology & Neurobiology
·
8
Evaluation of expiratory capacity with severe asthma following bronchial thermoplasty
2018
·
Satoru Ishii
, Motoyasu Iikura
, et al.
·
Respirology Case Reports
·
6
PDF
Differential immune-related microenvironment determines PD-1/PD-L1 blockade efficacy in advanced non-small cell lung cancer patients.
2021
·
Masayuki Shirasawa
, Tatsuya Yoshida
, et al.
·
Journal of Clinical Oncology
·
4
Forced oscillation technique as a predictor of airway hyper-responsiveness in asthma
2016
·
Taisuke Akamatsu
, Yuko Tanaka
, et al.
·
European Respiratory Journal
·
2
Use of virtual bronchoscopy to evaluate endobronchial TB
2021
·
T. Akamatsu
, Y. Shimoda
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
1
Multiomics Analysis of Malignant Pleural Mesothelioma Reveals the Immunological Microenvironment Associated with MTAP Loss and Immunotherapy Outcomes
2026
·
Akiko Tateishi
, Tatsuya Yoshida
, et al.
·
Clinical Cancer Research
MO1-6 Steroid-resistant and refractory irAEs requiring additional immunosuppressants to steroids in advanced NSCLC patients
2023
·
Yukiko Shimoda
, Tatsuya Yoshida
, et al.
·
Annals of Oncology
1366P Association between the adverse events and serum concentrations of lorlatinib in patients with advanced ALK-positive lung cancer
2023
·
Y. Shimoda
, T. Yoshida
, et al.
·
Annals of Oncology
PDF
Supplementary Material for: Contemplation of the effect of nivolumab plus cabosantinib therapy on cerebral hemorrhage in patients with brain metastasis of renal cell carcinoma: A case report
2023
·
Y., Sato
, Y., Kawasaki
, et al.
·
Figshare
MO39-4 An association between p16/MTAP status and the efficacy of cisplatin-plus-pemetrexed or nivolumab treatment of MPM
2022
·
Yuki Shinno
, Yukiko Shimoda
, et al.
·
Annals of Oncology
MO4-3 Adverse events of sequential tyrosine kinase inhibitor following immune checkpoint inhibitor in advanced NSCLC patients
2022
·
Yukiko Shimoda
, Jun Miyakoshi
, et al.
·
Annals of Oncology
Evaluation of pulmonary function after bronchial thermoplasty in the treatment of severe uncontrolled asthma using forced oscillation technique.
2018
·
Yukiko Shimoda
, Motoyasu Iikura
, et al.
·
European Respiratory Journal
Usefulness of Fractional Exhaled Nitric Oxide-Guided Treatment in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap
2018
·
Taisuke Akamatsu
, Toshihiro Shirai
, et al.
·
Open Journal of Respiratory Diseases
PDF
Effects of add-on treatment with budesonide/formoterol combination in eosinophilic COPD patients
2017
·
Taisuke Akamatsu
, Toshihiro Shirai
, et al.
·
European Respiratory Journal
Utility of the total step count during the 6-minute walk test in COPD
2016
·
Akito Yamamoto
, Taisuke Akamatsu
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
25
Citation count:
207
H-index:
9
I10-index:
7
Year
Topic
Type